This change was mirrored by a rise in serum MMPs, known for their crucial roles in promoting glioma invasiveness by facilitating the degradation of the extracellular matrix.48 This implies that ST2 deficiency could lead to a more aggressive tumor phenotype by facilitating tumor invasion and the formation of a more supportive environment for glioma growth. The gene discussed is IL1RL1; the disease is glioma.